Literature DB >> 8683129

Effect of endotoxin in IL-1 beta-deficient mice.

G Fantuzzi1, H Zheng, R Faggioni, F Benigni, P Ghezzi, J D Sipe, A R Shaw, C A Dinarello.   

Abstract

IL-1 plays an important role in the pathophysiologic responses to infection and inflammation, in part by mediating its own production and that of other proinflammatory cytokines. However, the relative contribution of IL-1 alpha and IL-1 beta to the inflammatory response has not been well clarified. Using IL-1 beta-deficient (IL-1 beta -/-) mice, we investigated the specific role of IL-1 beta in the in vivo and in vitro response to LPS. No differences between IL-1 beta +/+ and IL-1 beta -/- mice were observed in circulating levels for IL-1 alpha, IL-6, or TNF-alpha after the systemic administration of either a low (5 micrograms/kg) or high (5 mg/kg) dose of LPS. IL-1 beta -/- mice also had a normal response to LPS in terms of activation of the hypothalamus-pituitary-adrenal axis, hypoglycemia, serum amyloid A production, and anorexia. IL-1 beta -/- mice were normally sensitive to the lethal effect of LPS and were protected against LPS toxicity when pretreated with low-dose LPS. However, in vitro, peritoneal macrophages from IL-1 beta -/- mice stimulated with LPS produced significantly less IL-1 alpha than macrophages from IL-1 beta +/+ mice (p < 0.05). No differences in IL-6 or TNF-alpha synthesis were observed between macrophages from IL-1 beta +/+ and IL-1 beta -/- mice. In summary, our results suggest that either IL-1 beta is not essential for the in vivo systemic response to LPS or that its role can be fulfilled by other cytokines with overlapping activities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683129

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  New insights into the biology of the acute phase response.

Authors:  A F Suffredini; G Fantuzzi; R Badolato; J J Oppenheim; N P O'Grady
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

Review 2.  Cytokines in innate host defense in the lung.

Authors:  Robert M Strieter; John A Belperio; Michael P Keane
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.

Authors:  Antonia Fettelschoss; Magdalena Kistowska; Salomé LeibundGut-Landmann; Hans-Dietmar Beer; Pål Johansen; Gabriela Senti; Emmanuel Contassot; Martin F Bachmann; Lars E French; Annette Oxenius; Thomas M Kündig
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 4.  Targeting caspase-1 in sepsis: a novel approach to an old problem.

Authors:  Gustavo Matute-Bello
Journal:  Intensive Care Med       Date:  2007-03-24       Impact factor: 17.440

5.  IL-1 signaling in atherosclerosis: sibling rivalry.

Authors:  Frederick J Sheedy; Kathryn J Moore
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

6.  Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice.

Authors:  Senri Oguri; Katsutoshi Motegi; Yoichiro Iwakura; Yasuo Endo
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

7.  Antipyretic Effects of Citral and Possible Mechanisms of Action.

Authors:  Maycon T Emílio-Silva; Clarissa M D Mota; Clélia A Hiruma-Lima; José Antunes-Rodrigues; Evelin C Cárnio; Luiz G S Branco
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

8.  Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections.

Authors:  Yun-Gi Kim; Jong-Hwan Park; Thornik Reimer; Darren P Baker; Taro Kawai; Himanshu Kumar; Shizuo Akira; Christiane Wobus; Gabriel Núñez
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

9.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo.

Authors:  Melanie Scheibel; Bettina Klein; Heidrun Merkle; Manon Schulz; Ralph Fritsch; Florian R Greten; Melek C Arkan; Günter Schneider; Roland M Schmid
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.